11 results
P
Gracilis muscle transfer, Facial nerve, Masseter muscle
I/C
Contralateral facial nerve with cross-face nerve graft (CFNG), Motor nerve to the masseter (MNM), Dual innervation (DI), CFNG, MNM, DI
O
Commissure excursion, Facial symmetry, Clinical outcomes
P
patients with rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA)
I/C
coeliac disease (CD), biopsy-confirmed CD in RA and JIA patients
O
pooled prevalence estimates of biopsy-confirmed CD and positive CD serology
P
individuals who are overweight, those with obesity
I/C
exercise training, dietary interventions, dietary interventions, either Ex or DI alone
O
circulating leptin, adiponectin
P
adults with overweight and obesity
I/C
exercise training, dietary intervention, either Ex or DI alone
O
lipid profiles
P
soggetti esposti professionalmente a glifosato
I/C
esposizione professionale a glifosato, soggetti non esposti a glifosato
O
rischio di linfoma non Hodgkin (NHL) e mieloma multiplo (MM)
P
healthy adults
I/C
Endoflip™, measurements of esophageal motility, no intervention
O
esophagogastric junction distensibility index (EGJ-DI)
P
infants and young children
I/C
complementary feeding (CF)
O
optimal child growth, long and healthy life, influence on long-term health outcomes
P
5293
I/C
total glucosides of paeony, placebo, standard treatment
O
disease activity score (ASDAS), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), tumor necrosis factor (TNF)-α, interleukin (IL)-6, 28 joints disease activity (DAS28), psoriasis area and severity index (PASI), visual analogue scale (VAS), nitric oxide (NO)
P
patients with autoimmune disease and associated inflammatory ocular diseases
I/C
Janus kinase (JAK) inhibitors, . None of these 11 patients responded adequately to conventional treatments, including biological agents; these were all refractory cases and switched to JAK inhibitor therapy.
O
all 11 patients showed an improvement to JAK inhibitors without significant side effects
P
patients with diabetic foot ulcers
I/C
multidisciplinary team (MDT) approach, other organizational strategies
O
healing, minor and major amputation, survival
